Skip to main content

Table 1 IC50 values of DFX in three pancreatic cancer cell lines after a 72-h incubation

From: Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo

 

BxPC-3

HPAF-II

Panc 10.05

IC50 (μM)

7.3 ± 1.0

5.6 ± 1.0

6.1 ± 0.2

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us